Systemic inflammation and its response to treatment in patients with asthma

Respiratory Care

Volumn 56, Issue 6, 2011, Pages 800-805

  Girdhar, Ankur ^a   Kumar, Vivek ^a   Singh, Amita ^a   Menon, Balakrishnan ^b   Vijayan, Vk ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF DELHI   (India)

Author keywords

Acute phase reactants; Asthma; High sensitivity C reactive protein; Inhaled corticosteroids; Systemic inflammation

Indexed keywords

C REACTIVE PROTEIN; FLUTICASONE; SALBUTAMOL; SALMETEROL;

ADULT; AGE; ARTICLE; ASTHMA; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FAMILY SIZE; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LUNG FUNCTION TEST; MALE; PROTEIN BLOOD LEVEL; SYSTEMIC INFLAMMATION; TREATMENT RESPONSE;

ADULT; ASTHMA; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEUKOCYTE COUNT; LINEAR MODELS; MALE; RESPIRATORY FUNCTION TESTS; STATISTICS, NONPARAMETRIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 79960681909     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.00601     Document Type: Article

References (19)

1. Jousilahti PSV, Hakala K, Rasi V, Vahtera E, Palosuo T. The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol 2002;89(4):381-385.
2. Olafsdottir IS, Gislason T, Thjodleifsson B, Olafsson I, Gislason D, Jogi R, Janson C. C-reactive protein levels are increased in nonallergic but not allergic asthma: a multicentre epidemiological study. Thorax 2005;60(6):451-454.
3. Takemura M, Matsumoto H, Nilmi A, Ueda T, Matsuoka H, Yamaguchi M, et al. High sensitivity C-reactive protein in asthma. Eur Respir J 2006;27(5):908-912.
4. Global Initiative for Asthma (GINA); National Heart, Lung and Blood Institute (NHLBI). Global strategy for asthma management and prevention. Bethesda,MD;Updated 2010. http://www.ginasthma.com/Guidelineitem.asp??l1_2&l2_1&intId_60. Accessed April 11, 2011.
5. Enright P, Ward BJ, Tracy RP, Lasser EC. Asthma and its association with cardiovascular disease in the elderly. J Asthma 1996;33(1): 45-53.
6. Tracy RP. Inflammation in cardiovascular disease: cart, horse, or both? (editorial). Circulation 1998;97(20):2000-2002.
7. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999;45(12): 2136-2141.
8. Roberts WL, Sedrick R, Moulton L, Spencer A, Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem 2000;46(4):461-468.
9. Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J, Rifai N. Evaluation of nine automated high sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications. Part 2. Clin Chem 2001;47(3):418-425.
10. Kony S, Zureik M, Driss F, Neukirch C, Leynaert B, and Neukirch F. Association of bronchial hyperresponsiveness and lung function with C - reactive protein (CRP): a population based study. Thorax 2004;59(10):892-896.
11. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127(6):725-734.
12. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286(3):327-334.
13. Visser M, Bouter LM, McQuillen GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282(22):2131-2135.
14. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: association with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; (4):19:972-978.
15. Earl SF. Asthma, body mass index, and C-reactive protein among US adults. J Asthma 2003;40(7):733-739.
16. Hernández Velásquez L, Segura Méndez NH. Relation between asthma severity and body mass index. Case series. Rev Alerg Mex 2007;54(4):107-110.
17. Boulet LP, Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med 2007;101(11):2240-2247.
18. Maniscalco M, Zedda A, Faraone S, Cerbone MR, Cristiano S, Giardiello C, Sofia M. Weight loss and asthma control in severely obese asthmatic females. Respir Med 2008;102(1):102-128.
19. Sin DD, Lacy P, York E, Man SF. Effects of fluticasone on systemic markers of inflammation in COPD. Am J Respir Crit Care Med 2004;170(7):760-765.